Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-09 Imam Tariq SVP, Bus Dev, General Counsel Grant or award +15,000 39,579
2026-01-09 Imam Tariq SVP, Bus Dev, General Counsel Shares withheld for taxes −1,401 $1.97 $3K 38,178
2026-01-09 Imam Tariq SVP, Bus Dev, General Counsel Shares withheld for taxes −840 $1.97 $2K 37,338
2026-01-09 Imam Tariq SVP, Bus Dev, General Counsel Shares withheld for taxes −747 $1.97 $1K 36,591
2026-01-09 Imam Tariq SVP, Bus Dev, General Counsel Shares withheld for taxes −513 $1.97 $1K 36,078
2026-01-09 Imam Tariq SVP, Bus Dev, General Counsel Grant or award · Stock Option (Right to Buy) +7,000 7,000
2026-01-09 Nisco James SVP, Fin/Treas, Chief Actg Off Grant or award +15,000 38,491
2026-01-09 Nisco James SVP, Fin/Treas, Chief Actg Off Shares withheld for taxes −2,131 $1.97 $4K 36,360
2026-01-09 Nisco James SVP, Fin/Treas, Chief Actg Off Shares withheld for taxes −2,131 $1.97 $4K 34,229
2026-01-09 Nisco James SVP, Fin/Treas, Chief Actg Off Shares withheld for taxes −1,137 $1.97 $2K 33,092
2026-01-09 Nisco James SVP, Fin/Treas, Chief Actg Off Shares withheld for taxes −781 $1.97 $2K 32,311
2026-01-09 Nisco James SVP, Fin/Treas, Chief Actg Off Grant or award · Stock Option (Right to Buy) +7,000 7,000
2026-01-09 Buck Kristen K EVP, R&D and CMO Grant or award +25,000 104,794
2026-01-09 Buck Kristen K EVP, R&D and CMO Shares withheld for taxes −2,982 $1.97 $6K 101,812
2026-01-09 Buck Kristen K EVP, R&D and CMO Shares withheld for taxes −2,982 $1.97 $6K 98,830
2026-01-09 Buck Kristen K EVP, R&D and CMO Shares withheld for taxes −3,221 $1.97 $6K 95,609
2026-01-09 Buck Kristen K EVP, R&D and CMO Shares withheld for taxes −2,147 $1.97 $4K 93,462
2026-01-09 Buck Kristen K EVP, R&D and CMO Grant or award · Stock Option (Right to Buy) +13,000 13,000
2026-01-09 Flowers Cynthia Louise Director Grant or award +30,456 95,446
2026-01-09 BROWN GREGORY B Director Grant or award +30,456 95,659

Page 1 of 18 · 345 trades